Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended‐Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens

BACKGROUND AND OBJECTIVE: When patients seek to discontinue buprenorphine (BUP) treatment, monthly injectable extended‐release naltrexone (XR‐NTX) may help them avoid relapse. The efficacy of low ascending doses of oral NTX vs placebo for patients transitioning from BUP to XR‐NTX is evaluated in thi...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Am J Addict
Главные авторы: Comer, Sandra D., Mannelli, Paolo, Alam, Danesh, Douaihy, Antoine, Nangia, Narinder, Akerman, Sarah C., Zavod, Abigail, Silverman, Bernard L., Sullivan, Maria A.
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2020
Предметы:
Regular Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7383475/
https://ncbi.nlm.nih.gov/pubmed/32246728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajad.13024
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы